Kovitz Investment Group Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Kovitz Investment Group Partners's DXCM Position: Q4 2025 in Review
Kovitz Investment Group Partners sold out of DexCom (DXCM) in Q4 2025, closing a stake of 5,448 shares — an estimated $367K sold.
Kovitz Investment Group Partners first reported a position in DXCM in Q4 2024 and held it in 4 quarters. The position peaked at $1.93M in Q4 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- Kovitz Investment Group Partners reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
- Kovitz Investment Group Partners sold 5,448 DexCom shares in Q4 2025, an estimated $367K.
- Kovitz Investment Group Partners first reported a position in DexCom in Q4 2024 and held it in 4 quarters.
- Kovitz Investment Group Partners's DexCom position peaked at $1.93M in Q4 2024.
- 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.